Evidence map›Paper›PMID 31673365›Full record

SynthesisBMJ open respiratory research2019

Sex-specific incidence of asthma, rhinitis and respiratory multimorbidity before and after puberty onset: individual participant meta-analysis of five birth cohorts collaborating in MeDALL.

Cynthia Hohmann, Theresa Keller, Ulrike Gehring, Alet Wijga, Marie Standl, Inger Kull, Anna Bergstrom, Irina Lehmann, Andrea von Berg, Joachim Heinrich and 8 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in BMJ open respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life Course.American journal of respiratory and critical care medicine · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 5 countries.

Cynthia HohmannInstitute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0001-6612-3503
Theresa KellerInstitute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Ulrike GehringDepartment of Pulmonology, University Medical Centre Groningen Thoraxcentre, Groningen, The Netherlands.
Alet WijgaNational Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Marie StandlInstitute of Epidemiology, Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Umwelt und Gesundheit, Neuherberg, Germany.
Inger KullDepartment of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
Anna BergstromInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Irina LehmannMolecular Epidemiology Unit, Charité Universitätsmedizin Berlin, Berlin, Germany.
Andrea von BergResearch Institute, Department of Pediatrics, Marien-Hospital Wesel, Wesel, Germany.
Joachim HeinrichInstitute of Epidemiology, Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Umwelt und Gesundheit, Neuherberg, Germany.
Susanne LauDepartment of Paediatric Pneumology, Immunology and Intensive Care Unit, Charité Universitätsmedizin Berlin, Berlin, Germany.
Ulrich WahnDepartment of Paediatric Pneumology, Immunology and Intensive Care Unit, Charité Universitätsmedizin Berlin, Berlin, Germany.
Dieter MaierBiomax Informatics, Munich, Germany.
Josep AntoUniversitat Pompeu Fabra, Barcelona, Spain.
Jean BousquetUniversity Hospital Centre Montpellier, Montpellier, France.
Henriette SmitUtrecht University, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
Thomas KeilInstitute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Stephanie RollInstitute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEHelmholtz Zentrum München · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEBiomax Informatics (Germany) · DEKarolinska Institutet · SEMarien Hospital Wesel · DENational Institute for Public Health and the Environment · NLStockholm County Council · SEUniversitat Pompeu Fabra · ESUniversité de Versailles Saint-Quentin-en-Yvelines · FRUniversity Medical Center Groningen · NLUniversity of Würzburg · DEUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: To understand the puberty-related sex shift in the prevalence of asthma and rhinitis as single entities and as respiratory multimorbidities, we investigated if there is also a sex-specific and puberty-related pattern of their incidences. Methods: We used harmonised questionnaire data from 18 451 participants in five prospective observational European birth cohorts within the collaborative MeDALL (Mechanisms of the Development of Allergy) project. Outcome definitions for IgE-associated and non-IgE-associated asthma, rhinitis and respiratory multimorbidity (first occurrence of coexisting asthma and rhinitis) were based on questionnaires and the presence of specific antibodies (IgE) against common allergens in serum. For each outcome, we used proportional hazard models with sex-puberty interaction terms and conducted a one-stage individual participant data meta-analysis. Results: Girls had a lower risk of incident asthma (adjusted HR 0.67, 95% CI 0.61 to 0.74), rhinitis (0.73, 0.69 to 0.78) and respiratory multimorbidity (0.58, 0.51 to 0.66) before puberty compared with boys. After puberty onset, these incidences became more balanced across the sexes (asthma 0.84, 0.64 to 1.10; rhinitis 0.90, 0.80 to 1.02; respiratory multimorbidity 0.84, 0.63 to 1.13). The incidence sex shift was slightly more distinct for non-IgE-associated respiratory diseases (asthma 0.74, 0.63 to 0.87 before vs 1.23, 0.75 to 2.00 after puberty onset; rhinitis 0.88, 0.79 to 0.98 vs 1.20, 0.98 to 1.47; respiratory multimorbidity 0.66, 0.49 to 0.88 vs 0.96, 0.54 to 1.71) than for IgE-associated respiratory diseases. Discussion: We found an incidence 'sex shift' in chronic respiratory diseases from a male predominance before puberty to a more sex-balanced incidence after puberty onset, which may partly explain the previously reported sex shift in prevalence. These differences need to be considered in public health to enable effective diagnoses and timely treatment in adolescent girls.

Indexed as

PubertyAdolescentAge FactorsAsthmaChildCohort StudiesFemaleHumansIncidenceMaleMultimorbidityRespiratory Tract DiseasesRhinitisSex DistributionallergyasthmaincidenceMeDALLpubertyrespiratory multimorbidityrhinitissex shift

Identifiers

PMID31673365
PMCPMC6797252
OpenAlexW2973126290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.